Objectives 1. Recognize and identify the continuum of depth of sedation. 2. Discuss the complexity of the current practice of pediatric procedural sedation. 3. Outline the principles of creating a sedation plan in children. 4. Review pharmacological principles of the most common sedatives.
gasroentrologists, and podiatrists. This practitioner heterogeniety has resulted in a complex healthcare landscape in which little consensus exists among providers regarding who should deliver this service, and how it should be delivered. 3, 4 The practice variation has induced a call for more consistent guidelines in an effort to improve patient safety and sedation efficiency. 5 Anesthesiologists have been at the forefront of safety guideline development for PS. In 1983, the first sedation guidelines were published in response to 3 deaths in a dental office. 6 Since then, many organizations including the American Society of Anesthesiology (ASA), the American Academy of Pediatrics (AAP), and the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) have created standards for institutional policy development in pediatric PS. In 2004, JCAHO published their Comprehensive Accreditation Manual for Hospitals, intended to set standards for sedation and anesthesia care for patients in all clinical settings. The JCAHO Manual was updated in 2007, with a new mandate that individuals administering moderate or deep sedation be qualified and credentialed to manage all levels of sedation. In 2011, the Center for Medicaid and Medicare Services (CMS) published their guidelines that are consistent with the ASA's qualification requirements for deep sedation in which this practice is not restricted to anesthesiologists. [7] [8] [9] Under these guidelines, Registered Nurses are no longer qualified to administer deep sedation. The sedation provider must be a physician, nurse anesthetist, or anesthesia assistant. Any qualified specialist can play the main role in privileging programs for sedation. Currently at most institutions, the director of anesthesia services determines the proficiency and competency. In general, the required skills and competencies include performance of a preprocedural risk analysis, knowledge and experience of applied sedatives, implementation of the necessary monitoring and surveillance, identification and interpretation of sedation levels, and recognition and management of any unwanted adverse effects, particularly hypoventilation and airway obstruction.
Currently, there is a lack of universally accepted credentialing process for providers of pediatric sedation. Many institutions, including our own, require certification in Pediatric Advanced Life Support and Basic Life Support, as well as satisfactory performance on an examination after an online review of sedation educational content. Some centers recommend simulation-based training for nonanesthesiologists. 10 The quality of training becomes particularly important in remote areas of the hospital or in the office setting where assistance is difficult to provide in the event of a life-threatening emergency. We consider that equal safety precautions and requisite technical skills should be in place when any type of PS greater than mild sedation is provided; irrespective of which sedative is chosen. Consequently, it is wise to formulate separate recommendations regarding professional skills and competence for mild sedation on one hand and for moderate to deep sedation on the other hand (Tables 1, 2) . 11 
'

Sedation Levels and Available Pediatric Sedation Scales
The Joint Commission, the ASA, and the AAP have recently revised their definitions of the levels of PS. The 4 levels of sedation shown in Table 3 are now minimal, moderate, deep, and general. 5, 12 Although sedation levels are described as discrete entities, it must be recognized that sedation exists on a dynamic continuum, and that levels of sedation can change rapidly. This dynamic quality of sedation leads to the principle that the individual performing sedation must be capable of rescuing a patient from a depth of general anesthesia, implying that the clinician is skilled in advanced airway management and the treatment of cardiorespiratory compromise.
Sedation scales are scoring systems that describe the level of consciousness. Unfortunately, there is no ideal sedation scale available in pediatrics. However, there are number of validated sedation scales currently utilized to allow practitioners to intervene, instead of having to rescue the patient from complications related to increasing depth of In order to guarantee optimal levels of safety and effectiveness during a PS involving (a possibility of) moderate-to-deep sedation, the PS must be carried out by a separate professional that is not involved in the actual procedure (2) During a PS involving (a possibility of) moderate or deep sedation and during the subsequent recovery phase, a professional must be present with at least the following additional competence and skills:
(1) The ability to assess and interpret the sedation depth (2) The ability to guarantee the necessary monitoring of vital parameters, including capnography, and being able to appraise and interpret the monitored information 3) The use of antagonists (3.4) Heart massage techniques sedation. The most commonly used pediatric sedation scales include Ramsay Scale, 13 the Observer's Assessment of Alertness/Sedation Scale, 14 the COMFORT Scale, 15 University of Michigan Sedation Scale, 16 and Dartmouth Operative Conditions Scale. 17 Defining sedation depth based on responsiveness is inherently limited, as the implicit need to stimulate the patient in order to assess the sedation level. Moreover, this approach is challenged in circumstances when children are unable to respond appropriately, such as with the hearing impaired, the neurologically or developmentally compromised, or those who are preverbal or who speak a foreign language. Recently, Green and Mason 18 advocate for a reformulation of the assessment of Safe and effective PS begins with a careful presedation evaluation focusing on the underlying medical conditions. The age and maturity of the patient and the nature of the procedure dictate the required sedation depth. Therefore, the formulation of a sedation plan depends on the patient's age, comorbidities, allergies, and the requirements of the study or procedure. Specific institutional practices influence the selection of an agent. Some interventions are performed with minimal alteration in consciousness. Other procedures are better served under deeper levels of sedation or general anesthesia. In general, young children do not tolerate discomfort or immobility. Nonstimulating procedures, when lengthy, often require sedation as well. The sedation provider must ask about previous sedation or anesthesia, as a history of a failed sedation or other complications will undoubtedly influence the sedation plan.
It is critical to differentiate children for whom sedation can be provided by a nonanesthesiologist and children who require anesthesiology management. Every Department of Anesthesiology must assigned an anesthesiologist with expertise on PS to whom nonanesthesiologists may direct questions regarding sedation planning. This leader should be familiar with institutional sedation guidelines, the broad requirements for PS, and the clinical and systemic limitations within the institution that impact clinical care.
Patients receiving moderate or deep sedation should abide by the same NPO guidelines as patients receiving general anesthesia, as sedation levels may rapidly change with impairment of airway reflexes. The ASA guidelines for fasting are 8 hours from the intake of a meal that includes fried or fatty foods, 6 hours after the patient receives infant formula or a light meal, 4 hours after breast milk, and 2 hours after clear liquids. 20 It is important to recognize that these guidelines are based on consensus opinion rather than evidence. Furthermore, the guidelines acknowledge that there is "insufficient" evidence to address the relationship between the preoperative fasting period and aspiration risk. We also lack guidance regarding specific fasting recommendations for emergency procedures.
procedures in children who have not fasted, the risks of sedation and the possibility of aspiration must be balanced against the benefits of performing the procedure with an unprotected airway. The American College of Emergency Physicians (ACEP) advisory includes a minimum of 3 hours of fasting and approves of sedation at specific levels based on the nature of liquid or solid ingested and the urgency of the procedure. 21 Aspiration was found to be very rare among patients sedated in an emergency room setting for procedures despite not being appropriately fasted. 22 In another study, 2 aspiration events occurred in a population of over 16,000 children sedated for radiologic procedures. 23 Approximately two thirds of aspiration occurs during manipulations of the airway (endotracheal tube placement and removal). Although most patients undergoing general anesthesia have cuffed endotracheal tubes in place, aspiration can occur despite such protection. 24 The low incidence of aspiration during sedation has been attributed to maintenance of protective airway reflexes. However, rapid progression from mild sedation or analgesia to general anesthesia may occur. 25 The management of children who require oral contrast for computed tomography (CT) scan is controversial. Our institutional protocol begins contrast administration 2 hours and ends 1 hour before PS. The challenge lies in balancing technical factors governing the image quality of the study with safety concerns related to sedating a child with a potentially full stomach for an elective CT. There is considerable variation in sedation/ anesthesia practices and in airway management techniques. Currently, there is no consensus among institutions. Different anesthetic plans include rapid sequence induction of general anesthesia with tracheal intubation, deep sedation without airway protection, oral contrast given 2 hours before the study or administered through an oral gastric tube after placement of an endotracheal tube. 26, 27 '
Monitoring Patients During and After PS
The ASA has established guidelines for monitoring during moderate and deep sedation. 28 These guidelines represent recommendations rather than standards of practice. Many of the principles of basic physiological monitoring during general anesthesia apply during moderate and deep sedation including the presence of qualified personnel, hemodynamic monitoring with electrocardiography (in selected patients during moderate sedation), noninvasive blood pressure measurements at least every 5 minutes (unless such monitoring interferes with the sedation level), pulse oximetry and continuous monitoring of patient's ventilation by clinical evaluation, or in deep sedation with exhaled carbon dioxide (end-tidal CO 2 ). During moderate sedation, end-tidal CO 2 monitoring is recommended when conditions limit the ability to observe the patient. Respiratory rate monitoring with transthoracic impedance is considered inaccurate and unreliable. Considering the risk of excessive sedation, the level of consciousness must be regularly assessed. However, this recommendation has limitations during the sedation of children when stimulation impedes the completion of a diagnostic procedure. Documentation of recorded monitored parameters during PS is obligatory, beginning before sedation is administered and ending at the time of discharge.
Adapting these guidelines to every clinical setting is a challenge, particularly when the environment is designed for the proceduralist rather than the sedation provider. Sedation providers commonly face many safety issues, including limited patient access, poor lighting, and equipment that cannot be used in every environment. In these settings, reliable and accurate physiological monitoring is critical for patient safety. Anesthesiologists should assist in the early design phases of procedural and diagnostic rooms so that appropriate sedation resources are in place. 29 Sedation for radiotherapy and magnetic resonance imaging (MRI) is associated with unique monitoring challenges. Sedation providers are often physically isolated from patients. In this setting, remote video monitoring provides visualization the patient's chest wall movement. Because of risk of burns when applying standard pulse oximeters and EKG leads 30 in the MRI suit, "MRI compatible" monitors based on fiberoptic technology for signal acquisition should be used. These technologies promote more accurate and reliable monitoring due to their resistance to artifact.
'
Review of Medications Used for Pediatric Sedation
The following section reviews the most commonly used medications presently administered for pediatric sedation. See Table 4 for dose recommendations and specific considerations.
Barbiturates
It is useful as a single agent for noninvasive procedures providing a deep sedation level through stimulation of GABA A receptors. Pentobarbital, the most common barbiturate used for PS to children, can be administered orally, intramuscularly, rectally, and intravenously. Intravenous route produces the most predictable sedation in children. In infants, oral pentobarbital is highly effective with slower onset, less oxygen desaturation, and similar time to discharge readiness when compared with intravenous pentobarbital. 31 Oral pentobarbital has a mean time to sedate of 19 ± 14 minutes, a sedation length of 81 ± 34 minutes, and a discharge time of 100 ± 35 minutes. 32 It preserves respiratory and cardiovascular function with minimal respiratory depression. Unsuccessful sedation is as low as 0.3%. Rare side effects include paradoxical excitation, prolonged sedation, and transient oxygen desaturation. It has a long half-life of 24 hours; consequently, parents must be aware of the potential for prolonged somnolence and irritability. The intravenous preparation of pentobarbital contains 40% propylene glycol, which can cause metabolic acidosis, seizures, and renal failure especially with larger doses and intravenous continuous infusion. Pentobarbital induces CYP3A4; medications metabolized by this pathway, such as calcium channel blockers, can lose their effectiveness. Thiopental and methohexital have been used safely for radiographic sedation in children. 33 Methohexital has a shorter half-life than thiopental and should be avoided in patients with temporal lobe epilepsy due to its potential to cause seizures. 34 
Benzodiazepines
It is used as an anxiolytic with minimal cardiorespiratory depression when not coadministered with other sedatives. Midazolam is the most commonly used benzodiazepine due to its short (2.5 h) half-life. Benzodiazepines are rarely used as the sole sedation agent as it lacks sufficient potency to result in deep sedation unless used at very high doses. Different routes of administration includes oral, intranasal, intramuscular, or intravenous.
Propofol
It is a potent hypnotic agent used as an induction agent and sedative in children. It should be used with caution as it may result in upper airway obstruction and apnea. Its administration requires continuous monitoring and providers skilled in advanced airway management. The provider using propofol should never be involved with the diagnostic or therapeutic procedure, as a loss of airway control demands immediate intervention. Propofol administration by nonanesthesiologists has generated tremendous controversy. The ASA guidelines specifically state that personnel qualified to provide general anesthesia should only administer this medication.
Fospropofol
It is a water-soluble (rather than a lipid emulsion like propofol) prodrug that is converted to propofol by hydroxylation. It is an aqueous solution with some advantages over propofol including lower potential for contamination and decreased pain on injection. Its onset of action is slower, and its duration is longer than propofol. This drug is not yet approved for patients younger than 18 years of age.
Dexmedetomidine (DEX)
It is a highly selective a2-adrenoceptor agonist with sedative, anxiolytic, and limited analgesic effects. Inhibition of sympathetic outflow from the locus ceruleus in the brainstem results in sedation and anxiolysis. It has a half-life of 2 to 3 hours, and its clearance decreases with hepatic impairment. DEX is available for intravenous administration, although intramuscular, intranasal, subcutaneous, and epidural administration has been reported. Although it is not FDA approved in children, it is widely used as an adjunct to pediatric anesthesia and pediatric sedative in many settings. In contrast to other sedative agents, DEX has been shown to have sedative properties that mimic natural sleep, without significant respiratory depression. 35 Electroencephalograms in children under DEX sedation resemble those during nonrapid eye movement sleep. 36 Even in relatively high doses, DEX has little effect on airway caliber in children, 37 making this agent attractive in children with obstructive sleep apnea. 38 DEX has been used as the sole sedative agent providing reliable, effective, and hemodynically stable sedation in a variety of clinical settings including cardiac catheterization suite, radiology, and in intensive care. We administer DEX as an intravenous bolus of 1 to 3 mg/kg over 10 minutes followed by infusion rates of 1 to 3 mg/kg/h when used as the sole sedative. Transient hypertension and bradycardia has been reported during bolus administration.
38,39 DEX administration should proceed through an initial loading infusion, followed by a maintenance infusion, rather than rapid intravenous bolus to avoid hypertension and reflex bradycardia. Hypotension and bradycardia are the most common adverse reactions associated with the use of DEX. Exaggerated hypertension has been reported after the administration of glycopyrrolate to treat bradycardia. 40 
Ketamine
It is a phencyclidine derivative inducing a dissociative state by blocking communication pathways between the thalamus and the limbic system. It has analgesic properties with minimal cardiovascular depression, with the exception of the catecholamine-depleted patients. It is frequently administered during painful procedures such as dressing changes in burn patients and closed reduction of fractures in children. Unpleasant experiences associated with the administration of ketamine to children including hallucinations, agitation, and nightmares occur in 1% to 4%. 41 These behavioral reactions are not different from young to older children. 41 A meta-analysis of >8000 PS with ketamine administered by emergency physicians found a 3.9% incidence of a respiratory event with highest risk on children younger than 2 years and older than 13 years, the use of high intravenous doses (initial dose >2.5 mg/kg or total dose > 5 mg/kg), and the administration of anticholinergics. 42 Despite these results, the adverse events of ketamine are quite different than other agents, with higher incidence of hypertension, nausea, and vomiting and lower risk of respiratory events.
Opioids
These are commonly used during invasive procedures, although rarely for diagnostic imaging except as a rescue drug in cases of failed sedation or when dose limits of other sedatives have been exceeded. Fentanyl is commonly used in this setting due to its rapid onset and short half-life. Caution should be exercised when opiates are combined with other sedatives as the risk of respiratory depression is substantial. Naloxone, an opiate antagonist, should be readily available when opiates are used. Naloxone administration can be associated hypertension, tachycardia, pulmonary edema, and uncontrolled pain. The administration of opioids during PS increases the incidence of nausea, vomiting, and pruritus in the recovery period.
Chloral Hydrate
It is given by oral or rectal route. Its highly variable absorption can result in unpredictable onset, prolonged sedation, and persistent residual somnolence. An oral dose of 50 mg/kg in infants is as effective as oral pentobarbital with regard to onset of sedation and time to discharge. Desaturation is more common after chloral hydrate administration than with pentobarbital. 43 
Nitrous Oxide
It is commonly used during PS in the emergency department as well as during dental procedures. It has been used in concentrations from 30% to 70%. Sporadic report of seizures was reported during dental procedures. 44 The side effects of sedatives are dose dependent. Therefore, combining medications with different pharmacokinetic and pharmacodynamic profiles have the possible advantages of increasing efficacy and decreasing the side effects. One of these coadministered sedatives is propofol and ketamine. This combination has the potential of decreasing the risk of respiratory depression and hypotension with propofol, and decreasing the incidence of hallucinations, agitation, nightmares, nausea, and vomiting with the administration of ketamine. A prospective randomized controlled study in pediatric patients undergoing cardiac catheterization found that at a propofol:ketamine ratio of 10:2 (10 mg/mL of propofol and 2 mg/mL of ketamine) provides better hemodynamic profile without affecting the recovery time. 45 Similar findings were found in a prospective study using higher concentrations of ketamine (propofol:ketamine ratio 10:5) on pediatric patients undergoing cardiac catheterization. 46 In pediatric burn patients, propofol ketamine infusions have also found more effective than propofol fentanyl infusion for dressing changes. 47 Multiple studies have been done in the emergency room setting, comparing the administration of propofol ketamine versus the administration of ketamine both as a bolus. All of them include small number of patients and have shown conflicting results and its role is not defined. 48 During monitorized anesthetic care in adults, a study using 3 different mixtures of propofol and ketamine (propofol: ketamine 10:1, 10:2, and 10:3) showed that ketamine provides analgesia and reduces the administration of supplementation with opioids. However, in the largest ketamine group dose, there was an increase incidence of nausea, vomiting, psychomimetic effects, and prolonged discharge times. 49 In conclusion, the administration of propofol and ketamine on continuous infusion have shown clear advantages on children with congenital or acquired heart disease especially on those with labile hemodynamics and in burned children. However, there is no support of using this combination for routine sedation in children without cardiovascular disease. Current studies use different regimens of propofol and ketamine with different end-points and further studies in children are necessary to better evaluate the efficacy of propofol-ketamine given simultaneously.
Adverse Sedation Events and Risks Related to Pediatric Sedation
The Pediatric Sedation Research Consortium is a group of 37 institutions that have combined their sedation data to generate powerful insights into adverse events during PS. The consortium has pooled data from highly organized sedation services with robust sedation competencies. Their analysis of >30,000 PS provided by anesthesiologists, intensivists, emergency physicians, and hospitalists during therapeutic or diagnostic studies with the use of different sedatives (50% propofol) outside the operating room demonstrated that major complications were uncommon, and when they did occur were benign in nature when managed by skilled personnel. However, the incidence of airway intervention (including need for an oral airway, positive pressure ventilation, or intubation) was 1:200 and the incidence of apnea, laryngospasm, stridor, or wheezing was approximately 1:400. 50 Therefore, airway interventions during PS are frequently necessary to prevent serious complications; thus, sedation personnel must be capable of immediate recognition and management of respiratory impairment. Another report from the same group included almost 50,000 PS with the administration of propofol by anesthesiologists and nonanesthesiologists providers. Like their earlier findings, major complications such as aspiration and cardiac arrest were uncommon, and no deaths were reported. The incidence of airway obstruction, apnea, laryngospasm, bronchospasm, stridor, or wheezing was 1:65, 51 suggesting that propofol is associated with a higher incidence of respiratory complications when compared with other agents. No differences in complication rates were identified when the performance of anesthesiologists were compared with nonanesthesiologists. The authors conclude that propofol can be safely used for PS when administered by well-trained and well-organized sedation groups. In their largest study to date (>130,000 patients), the Pediatric Research Consortium shows similar complication rates regardless of specialty. 52 Large studies (>25,000 infants and children) of propofol PS administered by emergency physicians and pediatric hospitalists showed similar results with a low incidence of serious events with no long-term complications. 53, 54 Data from anesthesiologists providing PS in a high-risk group (70% of patients were ASA 3 and 4) during imaging studies with propofol found 98 adverse events from almost 1500 anesthetics with no long-term complications and predictors of complications found were ASA physical status, duration of anesthetic, and presence of airway abnormalities. 55 Across sedation studies the profile of adverse events is similar, with airway obstruction occurring most commonly followed by desaturation and apnea. Laryngospasm and hemodynamic changes were uncommon. In conclusion, well-organized sedation services that guarantee appropriate credentials and competencies in nonanesthesiologists showed low incidence of adverse events during propofol sedation suggesting a safety profile and efficacy. These results cannot be generalized to all nonanesthesiologists providers of PS. 56 Standardized definitions of the different adverse events during PS have been developed and are expected to better define the complications profile and help in to developing evidence-based care during PS and determine acceptable rates of adverse events. 57 Allergic reactions to contrast, including anaphylaxis, are another adverse event during PS. The previous incidence of any reaction was as high as 5% with a third of these severe. 58 Improvements in the practice with the use of nonionic iodinated low-osmolality contrast have decreased the incidence to 0.18% with 80% of those mild and just 15% severe. 59 Rapid recognition, basic support, volume resuscitation, epinephrine, antihistamines, and corticosteroids constitute the mainstay therapy. Different regimens are used to premedicate with steroids and antihistamines in patients with previous allergic reactions to contrast. Usually PO steroids are given 13, 7, and 1 hour before the exposure and antihistamines 1 hour before the exposure. Severe reactions may still occur despite premedication with steroids and use of low-osmolar contrast agents. Typically, the breakthrough reaction is of similar severity to the patient's initial reaction. Children with history of severe or life-threatening reactions have a 24% risk of having a similar reaction despite the administration of corticosteroids. 60 The radiation exposure to children is another risk. The largest exposure to radiation in the pediatric population occurs during CT studies. Children are more sensitive to radiation. Advances on CT technology have decreased the exposure to radiation. Working as a team with radiologists, referring physicians and technologists, is important to protect children of excessive and sometimes unnecessary radiation. Precontrast and postcontrast scans double or even sometimes triple the exposure to radiation.
Unique risks occur in the MRI. Magnetic field strength creates a risk environment where mishaps with ferromagnetic objects can potentially happen with disastrous consequences. New technology has increased the power of the magnets increasing from 1.5 to 3.0 T with better image resolution, but also with stronger magnetic fields. Formal procedures, extreme vigilance, and familiarity with the MRI environment are necessary. Screening of patients and parents for the presence of a pacemaker, vascular clip, insulin pump, and cochlear implant is essential. Special precautions must be used when using infusion pumps. The use of MRI compatible infusion pumps is highly recommended. Non-MRI compatible pumps must remain distant from the MRI magnetic field or be mounted outside the MRI scanner and fitted with appropriately long extension tubing. Ferromagnetic tracheostomies in children (Bivona; Smiths Medical, Kent, UK) must be changed by nonferromagnetic tracheostomies. Besides the risk related to ferromagnetic objects, children are at risk of burns from objects that heat during MRI, malfunction of implanted devices, allergic reaction to contrast agents, and hearing impairment due to the loud noisy environment. During emergency situations, quenching of the magnet could be necessary to remove a ferromagnetic object. The magnet is made of coils of superconducting wire that requires constant cooling by helium. During quenching, there is significant risk of hypoxic mixtures due to escape of helium and risk of hearing impairment due to the extreme noisy levels. A 1.5-and a 3-T MRI reach on average 95 and 99 dB, respectively. The Occupational Safety and Health Administration mandates to limit noise exposure of 95 dB to maximum 4 hours/day and 100 dB to 2 hours/day. Therefore, patients and relatives who stay in the MRI room must wear earplugs to protect against the high-intensity sound. Neonates and infants are at risk of hypothermia in the MRI due to continuous cooling of the room, which is necessary to guarantee the function of the magnet, and the noncompatibility of air-forced warming systems in the MRI. Therefore, use of warm blankets in the neonates is imperative. Gadolinium is a lowosmolality ionic contrast agent used to enhance the MRI images. Anaphylactoid reactions are extremely uncommon, but it is associated with nephrogenic systemic fibrosis in patients with impairment in the renal function. Therefore, its administration must be avoided in patients with renal failure. 61 Potential risks of adverse events during the recovery period mandates accessibility to basic monitoring, suction equipment, oxygen source, devices (mapleson or ambu bag) to provide positive pressure ventilation, and to specific antagonists of opioids and benzodiazepines. If the administration of an antagonist is necessary, which is extremely infrequent, continuous and prolonged monitoring is necessary given the shorter half-life of these agents with the risk of recurrent respiratory depression. The use of sedative regimens that includes the administration of reversal agents is not recommended. 28 An intravenous access must be maintained until the anesthesia provider considers the risk of having adverse events is minimum. 28 Specific discharge criteria include recovery of the level of consciousness and stable vital signs. Parents must be contacted within 24 hours of the procedure to evaluate the quality of care and detect late complications.
A PS database that includes complications provides input about the incidence and profile of the adverse events not only the most severe (respiratory and cardiovascular depression) but also untoward events such as failed sedation, paradoxical reactions, prolonged sedation, nausea, and vomiting.
Future of Pediatric Sedation
Pediatric sedation has undergone tremendous change during the past decade driven by a cultural shift that demands aggressive management of pain and anxiety in hospitalized children. New and safer sedative agents, using other alternative options for PS, changing the nature of education by using simulation, and finally collecting data from multispecialties to better determine and prevent adverse events are expecting changes in the practice of PS.
Improving Sedation Provider Training Education and Curriculum
The heterogenous guidelines followed by the diverse group of practitioners providing PS, and the varied environments in which care occurs, challenge us to provide uniformly safe and effective PS. It is imperative that practitioners performing pediatric PS have the requisite knowledge and medical skills demanded by this dynamic clinical environment. Unfortunately, many nonanesthesiologists are inadequately trained to respond to these challenges, putting children at risk. This training gap was highlighted in a recent study in which pediatric residents were unable to intubate the trachea of a child on the first attempt in almost 50% of cases. 62 Therefore, competency-related factors are important to improve practitioner training and ongoing maintenance of skills, as well as having rigorous credentialing procedures in place that ensure PS competency.
Individuals providing sedation must be capable of performing a presedation evaluation, have a depth knowledge of the sedation pharmacologic armamentarium, be skilled in the recognition and treatment of cardiopulmonary events, and have a thorough understanding of sedation procedures including monitoring, consent, recovery, and fasting guidelines. It is imperative that providers determine when the planned procedure, or the gravity of underlying disease in the child, precludes the use of sedation by a nonanesthesiologist. Practitioners must also recognize when and how to engage their emergency back-up systems in their unique practice environment. Basic credentials should include certification in Pediatric Advanced Life Support, Advanced Trauma Life Support, Adavanced Cardiovascular Life Support, or Neonatal Resuscitation Program. Furthermore, ongoing sedation education should be incorporated into each practitioner's maintenance of privileges.
Simulation in Pediatric Sedation
One of the most exciting training innovations in medicine has been the development of high-fidelity simulation. Similar to other high-risk organizations such as the aviation and nuclear power industries, medical simulation is emerging as a powerful and broadly applicable educational tool capable of exploring technical, behavioral, and systems issues within health care. Simulation is a technique that replaces or amplifies real experiences with guided experiences that evoke or replicate substantial aspects of the real world in a fully interactive manner. 63, 64 It allows the representation of a clinical event for the purpose of learning, practicing, evaluating, testing, and understanding human actions. 63 Simulation allows a specific lesson to be learned through experience that can be adjusted and repeated to suit the needs of the practitioner and institution, without putting patients at risk and also incorporating a review of educational content and debriefing by an expert facilitator to drive learning. 63 Emerging studies explore how simulation enhances pediatric sedation practice. A study in pediatricians compares a group that trained with simulation with those who did not and demonstrated that safety was enhanced when simulation was incorporated into physician training. 10 Simulation also addresses systemic failures that undermine patient safety. These systems-based "waiting to happen" issues are referred to as "latent errors." Blike et al 65 utilized simulation to evaluate latent errors impacting patient safety in children undergoing PS demonstrating that children in some clinical areas were at greater risk for prolonged hypoxemia than other areas. The authors argue that simulation provides a unique tool capable of exploring patient vulnerabilities in complex health care environments.
Studies evaluating performance among pediatric trainees demonstrate clear deficiencies in life-saving skills such as resuscitation and airway management. 66, 67 Medical simulation has tremendous potential to fill this gap between knowledge and action in an environment that is controllable, reproducible, and safe. Although there is a lack of strong evidence that simulation improves patient safety and outcomes, we are confident that pediatric simulation will emerge as a powerful tool for practitioner development and assessment, as well as a means to examine the functionality of health care systems. ' 
Conclusions
Pediatric anesthesiologists play a critical role on defining the competencies necessary among the different practitioners to provide pediatric PS. Consensus among the different specialties is critical.
Without this kind of cooperation and coordination between all providers, we will not be able to identify hazards and vulnerabilities and eventually will not be able to create and maintain a safe, productive, and efficient environment for pediatric sedation.
